DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

03692 HANSOH PHARMA

Closed Add to Porfolio
Index Constituent : Hang Seng Index, HS Composite Index, HS Comp.LargeCap Ind, HS Comp. L & M Index, HS China (HK) 100, Stock Connect HK Ind
Major Shareholders Zhong Huijuan (65.58%)
Cen Junda (15.47%)		 Sector Health Care & Biotechnology
Web Site http://www.hspharm.com Tel N/A
Email IR@hspharm.com Fax N/A
Related Equities N/A
Principal Activities The Group is principally engaged in the R&D, manufacture and sales of a series of pharmaceutical products in China.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top